Inhibition of endogenous NGF degradation induces mechanical allodynia and thermal hyperalgesia in rats

Molecular Pain

Volumn 9, Issue 1, 2013, Pages

  Osikowicz, Maria ^a   Longo, Geraldine ^a   Allard, Simon ^a   Cuello, A Claudio ^a   Ribeiro da Silva, Alfredo ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Allodynia; Hyperalgesia; Matrix metalloproteinase; Nerve growth factor; Sympathetic sprouting

Indexed keywords

ACETONE; GELATINASE A; GELATINASE B; NERVE GROWTH FACTOR; ENZYME INHIBITOR;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC INNERVATION; CONTROLLED STUDY; DERMIS; ENZYME ACTIVITY; ENZYME INHIBITION; GLABROUS SKIN; HYPERALGESIA; HYPERSENSITIVITY; INFLAMMATORY PAIN; MALE; NERVE SPROUTING; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RAT; SENSITIZATION; SENSORY ANALYSIS; SENSORY NERVE; SKIN NERVE; SYMPATHETIC NERVE; ANIMAL; DRUG EFFECTS; METABOLISM; SKIN; SPRAGUE DAWLEY RAT;

ANIMALS; ENZYME INHIBITORS; HYPERALGESIA; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NERVE GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; SKIN;

EID: 84880911821     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-9-37     Document Type: Article

References (86)

1. Lindsay RM. Neurotrophic growth factors and neurodegenerative diseases: therapeutic potential of the neurotrophins and ciliary neurotrophic factor. Neurobiol Aging 1994, 15:249-251. 10.1016/0197-4580(94)90124-4, 7838303.
2. Cuello AC. Nerve Growth Factor 2010, 823-830. Berlin: Springer: Encyclopedia of Psychopharmacology Volume 2.
3. Patel TD, Jackman A, Rice FL, Kucera J, Snider WD. Development of sensory neurons in the absence of NGF/TrkA signaling in vivo. Neuron 2000, 25:345-357. 10.1016/S0896-6273(00)80899-5, 10719890.
4. Crowley C, Spencer SD, Nishimura MC, Chen KS, Pitts-Meek S, Armanini MP, Ling LH, McMahon SB, Shelton DL, Levinson AD, et al. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 1994, 76:1001-1011. 10.1016/0092-8674(94)90378-6, 8137419.
5. Frade JM, Barde YA. Nerve growth factor: two receptors, multiple functions. Bioessays 1998, 20:137-145. 10.1002/(SICI)1521-1878(199802)20:2<137::AID-BIES6>3.0.CO;2-Q, 9631659.
6. Campenot RB. Local control of neurite sprouting in cultured sympathetic neurons by nerve growth factor. Brain Res 1987, 465:293-301.
7. Chen Y, Michaelis M, Janig W, Devor M. Adrenoreceptor subtype mediating sympathetic-sensory coupling in injured sensory neurons. J Neurophysiol 1996, 76:3721-3730.
8. Herzberg U, Eliav E, Dorsey JM, Gracely RH, Kopin IJ. NGF involvement in pain induced by chronic constriction injury of the rat sciatic nerve. Neuroreport 1997, 8:1613-1618. 10.1097/00001756-199705060-00012, 9189901.
9. Aloe L, Tuveri MA, Carcassi U, Levi-Montalcini R. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum 1992, 35:351-355. 10.1002/art.1780350315, 1536673.
10. Halliday DA, Zettler C, Rush RA, Scicchitano R, McNeil JD. Elevated nerve growth factor levels in the synovial fluid of patients with inflammatory joint disease. Neurochem Res 1998, 23:919-922. 10.1023/A:1022475432077, 9572681.
11. Lowe EM, Anand P, Terenghi G, Williams-Chestnut RE, Sinicropi DV, Osborne JL. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997, 79:572-577. 10.1046/j.1464-410X.1997.00097.x, 9126085.
12. Oddiah D, Anand P, McMahon SB, Rattray M. Rapid increase of NGF, BDNF and NT-3 mRNAs in inflamed bladder. Neuroreport 1998, 9:1455-1458. 10.1097/00001756-199805110-00038, 9631447.
13. Sarchielli P, Alberti A, Floridi A, Gallai V. Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology 2001, 57:132-134. 10.1212/WNL.57.1.132, 11445643.
14. Woolf CJ, Safieh-Garabedian B, Ma QP, Crilly P, Winter J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 1994, 62:327-331. 10.1016/0306-4522(94)90366-2, 7530342.
15. Dmitrieva N, McMahon SB. Sensitisation of visceral afferents by nerve growth factor in the adult rat. Pain 1996, 66:87-97. 10.1016/0304-3959(96)02993-4, 8857635.
16. Rueff A, Mendell LM. Nerve growth factor NT-5 induce increased thermal sensitivity of cutaneous nociceptors in vitro. J Neurophysiol 1996, 76:3593-3596.
17. Bruno MA, Cuello AC. Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc Natl Acad Sci USA 2006, 103:6735-6740. 10.1073/pnas.0510645103, 1458950, 16618925.
18. Allard S, Leon WC, Pakavathkumar P, Bruno MA, Ribeiro-da-Silva A, Cuello AC. Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype. J Neurosci 2012, 32:2002-2012. 10.1523/JNEUROSCI.1144-11.2012, 22323714.
19. Khan KM, Falcone DJ, Kraemer R. Nerve growth factor activation of Erk-1 and Erk-2 induces matrix metalloproteinase-9 expression in vascular smooth muscle cells. J Biol Chem 2002, 277:2353-2359. 10.1074/jbc.M108989200, 11698409.
20. Bennion BJ, Daggett V. The molecular basis for the chemical denaturation of proteins by urea. Proc Natl Acad Sci USA 2003, 100:5142-5147. 10.1073/pnas.0930122100, 154312, 12702764.
21. Bruno MA, Mufson EJ, Wuu J, Cuello AC. Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J Neuropathol Exp Neurol 2009, 68:1309-1318. 10.1097/NEN.0b013e3181c22569, 2810197, 19915485.
22. Dicou E, Perrot S, Menkes CJ, Masson C, Nerriere V. Nerve growth factor (NGF) autoantibodies and NGF in the synovial fluid: implications in spondylarthropathies. Autoimmunity 1996, 24:1-9.
23. Miller LJ, Fischer KA, Goralnick SJ, Litt M, Burleson JA, Albertsen P, Kreutzer DL. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 2002, 59:603-608. 10.1016/S0090-4295(01)01597-7, 11927336.
24. Watanabe T, Inoue M, Sasaki K, Araki M, Uehara S, Monden K, Saika T, Nasu Y, Kumon H, Chancellor MB. Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment. BJU Int 2011, 108:248-251. 10.1111/j.1464-410X.2010.09716.x, 20883485.
25. Sarchielli P, Gallai V. Nerve growth factor and chronic daily headache: a potential implication for therapy. Expert Rev Neurother 2004, 4:115-127. 10.1586/14737175.4.1.115, 15853622.
26. Albers KM, Wright DE, Davis BM. Overexpression of nerve growth factor in epidermis of transgenic mice causes hypertrophy of the peripheral nervous system. J Neurosci 1994, 14:1422-1432.
27. Purves D, Snider WD, Voyvodic JT. Trophic regulation of nerve cell morphology and innervation in the autonomic nervous system. Nature 1988, 336:123-128. 10.1038/336123a0, 3054564.
28. Ritter AM, Lewin GR, Kremer NE, Mendell LM. Requirement for nerve growth factor in the development of myelinated nociceptors in vivo. Nature 1991, 350:500-502. 10.1038/350500a0, 2014050.
29. Ruit KG, Osborne PA, Schmidt RE, Johnson EM, Snider WD. Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse. J Neurosci 1990, 10:2412-2419.
30. Davis BM, Albers KM, Seroogy KB, Katz DM. Overexpression of nerve growth factor in transgenic mice induces novel sympathetic projections to primary sensory neurons. J Comp Neurol 1994, 349:464-474. 10.1002/cne.903490310, 7852636.
31. Davis BM, Wang HS, Albers KM, Carlson SL, Goodness TP, McKinnon D. Effects of NGF overexpression on anatomical and physiological properties of sympathetic postganglionic neurons. Brain Res 1996, 724:47-54. 10.1016/0006-8993(96)00265-X, 8816255.
32. Goodness TP, Albers KM, Davis FE, Davis BM. Overexpression of nerve growth factor in skin increases sensory neuron size and modulates Trk receptor expression. Eur J Neurosci 1997, 9:1574-1585. 10.1111/j.1460-9568.1997.tb01515.x, 9283812.
33. Gorin PD, Johnson EM. Effects of long-term nerve growth factor deprivation on the nervous system of the adult rat: an experimental autoimmune approach. Brain Res 1980, 198:27-42. 10.1016/0006-8993(80)90341-8, 6105903.
34. Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci 1996, 19:289-317. 10.1146/annurev.ne.19.030196.001445, 8833445.
35. Almarestani L, Longo G, Ribeiro-da-Silva A. Autonomic fiber sprouting in the skin in chronic inflammation. Mol Pain 2008, 4:56. 10.1186/1744-8069-4-56, 2637239, 19014600.
36. Ruocco I, Cuello AC, Ribeiro-Da-Silva A. Peripheral nerve injury leads to the establishment of a novel pattern of sympathetic fibre innervation in the rat skin. J Comp Neurol 2000, 422:287-296. 10.1002/(SICI)1096-9861(20000626)422:2<287::AID-CNE9>3.0.CO;2-E, 10842232.
37. Yen LD, Bennett GJ, Ribeiro-da-Silva A. Sympathetic sprouting and changes in nociceptive sensory innervation in the glabrous skin of the rat hind paw following partial peripheral nerve injury. J Comp Neurol 2006, 495:679-690. 10.1002/cne.20899, 16506190.
38. Sato J, Perl ER. Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science 1991, 251:1608-1610. 10.1126/science.2011742, 2011742.
39. Bossut DF, Perl ER. Effects of nerve injury on sympathetic excitation of a delta mechanical nociceptors. J Neurophysiol 1995, 73:1721-1723.
40. Campbell NN, Reynolds GJ, Perkins G. Postoperative analgesia in neonates: an Australia-wide survey. Anaesth Intensive Care 1989, 17:487-491.
41. Grelik C, Bennett GJ, Ribeiro-da-Silva A. Autonomic fibre sprouting and changes in nociceptive sensory innervation in the rat lower lip skin following chronic constriction injury. Eur J Neurosci 2005, 21:2475-2487. 10.1111/j.1460-9568.2005.04089.x, 15932605.
42. Nauta HJ, Wehman JC, Koliatsos VE, Terrell MA, Chung K. Intraventricular infusion of nerve growth factor as the cause of sympathetic fiber sprouting in sensory ganglia. J Neurosurg 1999, 91:447-453. 10.3171/jns.1999.91.3.0447, 10470820.
43. Winkler J, Ramirez GA, Kuhn HG, Peterson DA, Day-Lollini PA, Stewart GR, Tuszynski MH, Gage FH, Thal LJ. Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor. Ann Neurol 1997, 41:82-93. 10.1002/ana.410410114, 9005869.
44. Isaacson LG, Saffran BN, Crutcher KA. Nerve growth factor-induced sprouting of mature, uninjured sympathetic axons. J Comp Neurol 1992, 326:327-336. 10.1002/cne.903260302, 1469116.
45. Saffran BN, Woo JE, Mobley WC, Crutcher KA. Intraventricular NGF infusion in the mature rat brain enhances sympathetic innervation of cerebrovascular targets but fails to elicit sympathetic ingrowth. Brain Res 1989, 492:245-254. 10.1016/0006-8993(89)90907-4, 2752299.
46. Andreev N, Dimitrieva N, Koltzenburg M, McMahon SB. Peripheral administration of nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones. Pain 1995, 63:109-115. 10.1016/0304-3959(95)00024-M, 8577480.
47. Woolf CJ, Ma QP, Allchorne A, Poole S. Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J Neurosci 1996, 16:2716-2723.
48. Lewin GR, Ritter AM, Mendell LM. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 1993, 13:2136-2148.
49. Lewin GR, Mendell LM. Regulation of cutaneous C-fiber heat nociceptors by nerve growth factor in the developing rat. J Neurophysiol 1994, 71:941-949.
50. Pertens E, Urschel-Gysbers BA, Holmes M, Pal R, Foerster A, Kril Y, Diamond J. Intraspinal and behavioral consequences of nerve growth factor-induced nociceptive sprouting and nerve growth factor-induced hyperalgesia compared in adult rats. J Comp Neurol 1999, 410:73-89. 10.1002/(SICI)1096-9861(19990719)410:1<73::AID-CNE7>3.0.CO;2-3, 10397396.
51. Malin SA, Molliver DC, Koerber HR, Cornuet P, Frye R, Albers KM, Davis BM. Glial cell line-derived neurotrophic factor family members sensitize nociceptors in vitro and produce thermal hyperalgesia in vivo. J Neurosci 2006, 26:8588-8599. 10.1523/JNEUROSCI.1726-06.2006, 16914685.
52. Petty BG, Cornblath DR, Adornato BT, Chaudhry V, Flexner C, Wachsman M, Sinicropi D, Burton LE, Peroutka SJ. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 1994, 36:244-246. 10.1002/ana.410360221, 8053664.
53. Dyck PJ, Peroutka S, Rask C, Burton E, Baker MK, Lehman KA, Gillen DA, Hokanson JL, O'Brien PC. Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology 1997, 48:501-505. 10.1212/WNL.48.2.501, 9040746.
54. Rukwied R, Mayer A, Kluschina O, Obreja O, Schley M, Schmelz M. NGF induces non-inflammatory localized and lasting mechanical and thermal hypersensitivity in human skin. Pain 2010, 148:407-413. 10.1016/j.pain.2009.11.022, 20022698.
55. Weinkauf B, Obreja O, Schmelz M, Rukwied R. Differential effects of lidocaine on nerve growth factor (NGF)-evoked heat- and mechanical hyperalgesia in humans. Eur J Pain 2011, 16:543-549.
56. Mills CD, Nguyen T, Tanga FY, Zhong C, Gauvin DM, Mikusa J, Gomez EJ, Salyers AK, Bannon AW. Characterization of nerve growth factor-induced mechanical and thermal hypersensitivity in rats. Eur J Pain 2013, 17:469-479. 10.1002/j.1532-2149.2012.00202.x, 22915527.
57. McLachlan EM, Janig W, Devor M, Michaelis M. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia. Nature 1993, 363:543-546. 10.1038/363543a0, 8505981.
58. Xie W, Strong JA, Zhang JM. Increased excitability and spontaneous activity of rat sensory neurons following in vitro stimulation of sympathetic fiber sprouts in the isolated dorsal root ganglion. Pain 2010, 151:447-459. 10.1016/j.pain.2010.08.006, 2955761, 20800969.
59. Bertrand PP. ATP and sensory transduction in the enteric nervous system. Neuroscientist 2003, 9:243-260. 10.1177/1073858403253768, 12934708.
60. Burnstock G. Therapeutic potential of purinergic signalling for diseases of the urinary tract. BJU Int 2011, 107:192-204. 10.1111/j.1464-410X.2010.09926.x, 21208364.
61. Mo G, Peleshok JC, Cao CQ, Ribeiro-da-Silva A, Seguela P. Control of P2X3 channel function by metabotropic P2Y2 utp receptors in primary sensory neurons. Mol Pharmacol 2013, 83:640-647. 10.1124/mol.112.082099, 23249537.
62. Longo G, Osikowicz M, Ribeiro-da-Silva A. Sympathetic fiber sprouting in inflamed joints and adjacent skin contributes to pain-related behavior in arthritis. J Neurosci 2013, 33:10066-10074. 10.1523/JNEUROSCI.5784-12.2013, 23761902.
63. Malmberg AB, Basbaum AI. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain 1998, 76:215-222. 10.1016/S0304-3959(98)00045-1, 9696476.
64. Xanthos DN, Coderre TJ. Sympathetic vasoconstrictor antagonism and vasodilatation relieve mechanical allodynia in rats with chronic postischemia pain. J Pain 2008, 9:423-433. 10.1016/j.jpain.2007.12.005, 18262849.
65. Kerr BJ, Souslova V, McMahon SB, Wood JN. A role for the TTX-resistant sodium channel Nav 1.8 in NGF-induced hyperalgesia, but not neuropathic pain. Neuroreport 2001, 12:3077-3080. 10.1097/00001756-200110080-00019, 11568640.
66. Brackenbury WJ, Djamgoz MB. Nerve growth factor enhances voltage-gated Na + channel activity and Transwell migration in Mat-LyLu rat prostate cancer cell line. J Cell Physiol 2007, 210:602-608. 10.1002/jcp.20846, 17149708.
67. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824. 10.1038/39807, 9349813.
68. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998, 21:531-543. 10.1016/S0896-6273(00)80564-4, 9768840.
69. Michael GJ, Priestley JV. Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy. J Neurosci 1999, 19:1844-1854.
70. Shu X, Mendell LM. Nerve growth factor acutely sensitizes the response of adult rat sensory neurons to capsaicin. Neurosci Lett 1999, 274:159-162. 10.1016/S0304-3940(99)00701-6, 10548414.
71. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288:306-313. 10.1126/science.288.5464.306, 10764638.
72. Donnerer J, Liebmann I, Schicho R. Differential regulation of 3-beta-hydroxysteroid dehydrogenase and vanilloid receptor TRPV1 mRNA in sensory neurons by capsaicin and NGF. Pharmacology 2005, 73:97-101. 10.1159/000081625, 15492487.
73. Xue Q, Jong B, Chen T, Schumacher MA. Transcription of rat TRPV1 utilizes a dual promoter system that is positively regulated by nerve growth factor. J Neurochem 2007, 101:212-222.
74. Zhang X, Huang J, McNaughton PA. NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J 2005, 24:4211-4223. 10.1038/sj.emboj.7600893, 1356334, 16319926.
75. Lewin GR, Rueff A, Mendell LM. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci 1994, 6:1903-1912. 10.1111/j.1460-9568.1994.tb00581.x, 7704300.
76. Bennett G, al-Rashed S, Hoult JR, Brain SD. Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils. Pain 1998, 77:315-322. 10.1016/S0304-3959(98)00114-6, 9808357.
77. Amann R, Schuligoi R, Herzeg G, Donnerer J. Intraplantar injection of nerve growth factor into the rat hind paw: local edema and effects on thermal nociceptive threshold. Pain 1996, 64:323-329. 10.1016/0304-3959(95)00120-4, 8740610.
78. Heppenstall PA, Lewin GR. Neurotrophins, nociceptors and pain. Curr Opin Anaesthesiol 2000, 13:573-576. 10.1097/00001503-200010000-00015, 17016360.
79. Jankowski MP, Koerber HR. Neurotrophic Factors and Nociceptor Sensitization. Translational Pain Research: From Mouse to Man 2010, Boca Raton, FL, Kruger L, Light AR, Chapter 2. Available from: http://www.ncbi.nlm.nih.gov/books/NBK57265/.
80. Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, Tan PH, Gao YJ, Roy K, Corfas G, Lo EH, Ji RR. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 2008, 14:331-336. 10.1038/nm1723, 2279180, 18264108.
81. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001, 17:463-516. 10.1146/annurev.cellbio.17.1.463, 2792593, 11687497.
82. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110. 10.1016/0304-3959(83)90201-4, 6877845.
83. Osikowicz M, Mika J, Makuch W, Przewlocka B. Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain. Pain 2008, 139:117-126. 10.1016/j.pain.2008.03.017, 18442882.
84. Choi Y, Yoon YW, Na HS, Kim SH, Chung JM. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 1994, 59:369-376. 10.1016/0304-3959(94)90023-X, 7708411.
85. Flatters SJ, Bennett GJ. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 2004, 109:150-161. 10.1016/j.pain.2004.01.029, 15082137.
86. Tallarida RJ, Murray RB. Manual of Pharmacologic Calculations with Computer Programs 1987, New York: Springer.